Everolimus for advanced breast cancer: Is the histological subtype important?

被引：0
|
作者：
Vargas, Alicia
Flores Paco, Pablo
De La Haba, Juan
Morales-Estevez, Cristina
Rodriguez-Alonso, Beatriz
Porras, Ignacio
de la Cruz-Merino, Luis
Munoz, Clara
Lorente, Margarita
Gonzalez Flores, Encarnacion
Sanchez-Rovira, Pedro
Arenas, Rafael
Armenta, Ana
Aranda, Enrique
机构：
[1] Univ Reina Sofia Hosp, Cordoba, Spain
[2] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain
[3] Univ Cordoba, Univ Reina Sofia Hosp, Cordoba, Spain
[4] GEICAM Spanish Breast Canc Grp, Cordoba, Spain
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Virgen Macarena Univ Hosp, Seville, Spain
[7] Virgen de las Nieves Univ Hosp, Granada, Spain
[8] Virgen de las Nieves Hosp, Granada, Spain
[9] Hosp Univ Jaen, Jaen, Spain
[10] GEICAM Spanish Breast Canc Grp, Jaen, Spain
[11] Univ Reina Sofia Hosp, Dept Med Oncol, Cordoba, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13165
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Staging laparoscopy in locally advanced gastric cancer: Beware the poorly differentiated histological subtype
    Souadka, Amine
    Essangri, Hajar
    Elazzaoui, Faysal
    Majbar, Mohammed Anass
    Benkabbou, Amine
    Mohsine, Raouf
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 625 - 626
  • [22] Histological subtype of gastric cancer in Japan
    Shitara, Kohei
    Muro, Kei
    LANCET ONCOLOGY, 2010, 11 (02): : 115 - 116
  • [23] Metastatic patterns in locally advanced and recurrent breast cancer: Is there any correlation with molecular subtype of breast cancer?
    Bansal, G. Jyoti
    Pinto, Kevin
    Davies, Eleri
    BREAST CANCER RESEARCH, 2017, 19
  • [24] Safety of everolimus in estrogen receptor-positive advanced breast cancer.
    Perez, Alejandra T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [25] Dietary inflammatory index and breast cancer risk by menopausal status and histological subtype.
    Castello, Adela
    Shivappa, Nitin
    Ruiz, Amparo
    Casas, Ana
    Hernandez, Ana Lluch
    Baena-Canada, Jose Manuel
    Antolin, Silvia
    Sanchez Rovira, Pedro
    Ramos Vazquez, Manuel
    Angel Garcia-Saenz, Jose
    Anton, Antonio
    Munoz, Montserrat
    de Juan, Ana
    Jara-Sanchez, Carlos
    Vioque, Jesus
    Perez-Gomez, Beatriz
    Hebert, James R.
    Lope, Virginia
    Martin, Miguel
    Pollan, Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Poor histological subtype and response to neoadjuvant treatment in triple-negative breast cancer
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (03): : 1665 - 1665
  • [27] Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer
    Aapro, M.
    Andre, F.
    Blackwell, K.
    Calvo, E.
    Jahanzeb, M.
    Papazisis, K.
    Porta, C.
    Pritchard, K.
    Ravaud, A.
    ANNALS OF ONCOLOGY, 2014, 25 (04) : 763 - 773
  • [28] Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2
    Prat, Aleix
    Christoph Brase, Jan
    Cheng, Yuan
    Nuciforo, Paolo
    Pare, Laia
    Pascual, Tomas
    Martinez, Debora
    Galvan, Patricia
    Vidal, Maria
    Adamo, Barbara
    Hortobagyi, Gabriel N.
    Baselga, Jose
    Ciruelos, Eva
    ONCOLOGIST, 2019, 24 (07): : 893 - 900
  • [29] The impact of histological subtype on postoperative recurrence pattern and timing in locally advanced esophagogastric junction cancer
    Maeda, Shinsuke
    Ota, Masaho
    Ito, Shunichi
    Hosoda, Kei
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [30] Impact of histological subtype on the response to chemoradiation in locally advanced cervical cancer and the possible role of surgery
    Voinea, Silviu
    Herghelegiu, Catalin Gabriel
    Sandru, Angela
    Ioan, Raluca Gabriela
    Bohiltea, Roxana Elena
    Bacalbasa, Nicolae
    Chivu, Laura Ioana
    Furtunescu, Florentina
    Stanica, Diana Catalina
    Neacsu, Adrian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (01)
12345